IL18 and breast cancer: Additionally, it has been suggested that IL-18 modulates the immune system for attacking cancer cells via inhibiting tumor growth and angiogenesis in ovarian cancer, attenuating cell proliferation and invasion ability in BC, and increasing the cytotoxic effects of the chemotherapeutic drugs on colon malignant cells (Jia et al., 2016).